Suppr超能文献

荚膜在多杀性巴氏杆菌A血清群引起的禽霍乱发病机制中的作用

Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.

作者信息

Chung J Y, Wilkie I, Boyce J D, Townsend K M, Frost A J, Ghoddusi M, Adler B

机构信息

Bacterial Pathogenesis Research Group, Department of Microbiology, Monash University, Victoria 3800, Australia.

出版信息

Infect Immun. 2001 Apr;69(4):2487-92. doi: 10.1128/IAI.69.4.2487-2492.2001.

Abstract

We have constructed a defined acapsular mutant in Pasteurella multocida X-73 (serogroup A:1) by disrupting the hexA gene through the insertion of a tetracycline resistance cassette. The genotype of the hexA::tet(M) strain was confirmed by PCR and Southern hybridization, and the acapsular phenotype of this strain was confirmed by electron microscopy. The hexA::tet(M) strain was attenuated in both mice and chickens. Complementation of the mutant with an intact hexAB fragment restored lethality in mice but not in chickens. In contrast to the results described previously for P. multocida serogroup B (J. D. Boyce and B. Adler, Infect. Immun. 68:3463-3468, 2000), the hexA::tet(M) strain was sensitive to the bactericidal action of chicken serum, whereas the wild-type and complemented strains were both resistant. Following inoculation into chicken muscle, the bacterial count of the hexA::tet(M) strain decreased significantly, while the wild-type and complemented strains both grew rapidly over 4 h. The capsule is thus an essential virulence determinant in the pathogenesis of fowl cholera.

摘要

我们通过插入四环素抗性盒破坏多杀性巴氏杆菌X-73(血清群A:1)中的hexA基因,构建了一个明确的无荚膜突变体。通过PCR和Southern杂交确认了hexA::tet(M)菌株的基因型,并通过电子显微镜确认了该菌株的无荚膜表型。hexA::tet(M)菌株在小鼠和鸡中均减毒。用完整的hexAB片段对突变体进行互补,可恢复小鼠的致死性,但不能恢复鸡的致死性。与先前报道的多杀性巴氏杆菌血清群B的结果(J.D. Boyce和B. Adler,《感染与免疫》68:3463-3468,2000)相反,hexA::tet(M)菌株对鸡血清的杀菌作用敏感,而野生型和互补菌株均具有抗性。接种到鸡肌肉中后,hexA::tet(M)菌株的细菌数量显著下降,而野生型和互补菌株在4小时内均快速生长。因此,荚膜是禽霍乱发病机制中一个重要的毒力决定因素。

相似文献

1
Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.
Infect Immun. 2001 Apr;69(4):2487-92. doi: 10.1128/IAI.69.4.2487-2492.2001.
2
Vaccination against fowl cholera with acapsular Pasteurella multocida A:1.
Vaccine. 2005 Apr 15;23(21):2751-5. doi: 10.1016/j.vaccine.2004.11.036.
3
The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).
Infect Immun. 2000 Jun;68(6):3463-8. doi: 10.1128/IAI.68.6.3463-3468.2000.
4
Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.
Infect Immun. 2001 Mar;69(3):1943-6. doi: 10.1128/IAI.69.3.1943-1946.2001.
6
Characterization of a 39kDa capsular protein of avian Pasteurella multocida using monoclonal antibodies.
Vet Microbiol. 2004 May 20;100(1-2):43-53. doi: 10.1016/j.vetmic.2004.01.017.
7
Construction and characterization of an OmpH-deficient mutant of Pasteurella multocida strain X-73.
Avian Pathol. 2019 Feb;48(1):4-11. doi: 10.1080/03079457.2018.1533239. Epub 2018 Oct 22.

引用本文的文献

1
Characterization of a Capsule-Deficient Isolated from : Genomic, Phenotypic, and Virulence Insights.
Microorganisms. 2025 Apr 29;13(5):1024. doi: 10.3390/microorganisms13051024.
2
3
isogenic capsular and LPS-sialylation gene deletion mutants are attenuated in a calf lung challenge model.
Microbiol Spectr. 2025 Jun 3;13(6):e0028325. doi: 10.1128/spectrum.00283-25. Epub 2025 Apr 23.
5
Molecular epidemiology and characterization of antibiotic resistance of isolated from livestock population of Punjab, Pakistan.
Int J Vet Sci Med. 2025 Feb 25;13(1):1-12. doi: 10.1080/23144599.2024.2437223. eCollection 2025.
7
Pathogenomic analysis and characterization of strains recovered from human infections.
Microbiol Spectr. 2024 Apr 2;12(4):e0380523. doi: 10.1128/spectrum.03805-23. Epub 2024 Mar 1.
10
The Role and Targets of the RNA-Binding Protein ProQ in the Gram-Negative Bacterial Pathogen Pasteurella multocida.
J Bacteriol. 2022 Apr 19;204(4):e0059221. doi: 10.1128/jb.00592-21. Epub 2022 Mar 24.

本文引用的文献

1
A role for exopolysaccharides in the protection of microorganisms from desiccation.
Appl Environ Microbiol. 1994 Feb;60(2):740-5. doi: 10.1128/aem.60.2.740-745.1994.
2
The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).
Infect Immun. 2000 Jun;68(6):3463-8. doi: 10.1128/IAI.68.6.3463-3468.2000.
5
The capsule biosynthetic locus of Pasteurella multocida A:1.
FEMS Microbiol Lett. 1998 Sep 15;166(2):289-96. doi: 10.1111/j.1574-6968.1998.tb13903.x.
7
Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida.
Vaccine. 1997 Feb;15(2):203-8. doi: 10.1016/s0264-410x(96)00139-9.
10
Capsular hyaluronic acid in Pasteurella multocida type A and its counterpart in type D.
Res Vet Sci. 1993 Jan;54(1):20-4. doi: 10.1016/0034-5288(93)90005-z.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验